← Eichor
Study identifier: NCT06596551 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Aspirational Rehabilitation Coaching for Holistic Health (ARCH): A Pilot Pre-Post Experimental Study

Condition: Stroke · Psychological Well-Being · Psychosocial Functioning  ·  Sponsor: Nanyang Technological University

PhaseNA
Planned participants60
Who can joinAll sexes, 21 Years to no upper limit
Healthy volunteersYes

About this study

The ARCH programme is a novel, strength-based, dyadic, multicomponent psychosocial intervention that blends together psychoeducation, psychosocial support and self-compassion practices to aid first-time stroke survivors and their family caregivers with their psycho-socio-emotional and spiritual challenges following discharge from in-patient care. A pre-post experimental design with a feasibility and acceptability assessment is adopted to evaluate and refine the ARCH intervention in promoting wellbeing, self-compassion, independence, quality of life, hope, resilience, self-efficacy and dyadic mutuality.

This description comes directly from the study's public registry record.

Talk to the study team

Andy HY Ho, PhD, EdD  ·  +65 6316 8943  ·  andyhyho@ntu.edu.sg

Shaik Muhammad Amin, MSc  ·  +65 94797633  ·  shaikmuh002@e.ntu.edu.sg

Always discuss trial participation with your own doctor first.

Locations (1)

Tan Tock Seng HospitalSingapore, SingaporeRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06596551